z-logo
open-access-imgOpen Access
Electrocardiographic Safety of Daily Hydroxychloroquine 400mg Plus Azithromycin 250mg as an Ambulatory Treatment for COVID-19 Patients in Cameroon
Author(s) -
Liliane Mfeukeu-Kuaté,
William Ngatchou,
Mazou Ngou Temgoua,
Charles Kouanfack,
Daniel Lemogoum,
Joël Noutakdie Tochie,
Armel Zemsi,
Lauriane Nomene Fomete,
Skinner Lekelem,
Sylvain Zemsi,
Joelle Sobngwi,
Thierry Ntandzi,
Christian Ngongang Ouankou,
Yves Wasnyo,
Antoinette Tsama Assiga,
Jan René Nkeck,
Ahmadou Musa Jingi,
Magellan Guewo,
Eric Walter Pefura Yone,
Charlotte Moussi Omgba,
Paul Owono Etoundi,
Jean Cyr Yombi,
Samuel Kingué,
Alain Menanga,
Jacqueline Ze Minkandé,
Jean Claude Mbanya,
Pierre OngoloZogo,
Pierre Joseph Fouda,
Eugène Sobngwi
Publication year - 2020
Publication title -
ssrn electronic journal
Language(s) - English
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.3627274
Subject(s) - medicine , azithromycin , hydroxychloroquine , qt interval , qrs complex , ambulatory , heart rate , placebo , cardiology , prospective cohort study , covid-19 , blood pressure , alternative medicine , disease , pathology , infectious disease (medical specialty) , microbiology and biotechnology , biology , antibiotics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom